| Prev Close | 150.81 |
| Day Low/High | 148.01 / 152.74 |
| 52 Wk Low/High | 110.66 / 160.16 |
Kimberly-Clark Corporation (KMB)
148.52
NYSE
| Exchange | NYSE |
| Shares Outstanding | 341.05B |
| Market Cap | 51.43B |
| P/E Ratio | 20.47 |
| Div & Yield | N.A. (N.A) |
Latest News
Freshen Up Your Portfolio With This Overseas Dividend Stock
Unilever has a clean history of delivering dividends, even when economic bubbles burst.
Sector Haves/Have Nots, Lisa Su Does It Again, Trading Tesla and Microsoft
Earnings reports continue to outperform, but can this support equity markets at these levels now?
Looking for Dependable Dividends? Look to Consumables
This area of investing is much larger than just food and drinks and includes health care products of all sorts -- including Patterson Companies.
Use DRIPs to Build a Socially Responsible Portfolio
Many quality companies that fit into the socially responsible investing camp offer direct-purchase plans, allowing investors an easy way to build an SRI portfolio.
Let's Play Dividend Detective to Find Out Where to Uncover Good Yields
While many companies are cutting their dividends, others are holding strong and some are poised to see increases. Here's how to spot the good opportunities.
Kimberly-Clark Is Poised to Break Out to New Highs: Here's What to Do
With so many weak-looking charts it is uplifting to look at KMB.
Cramer: The Stock Market Is Now Divided Into 3 Buckets - And One Is Unfortunate
The problem for index fund owners is they own all three buckets and there are a lot more companies in the third bucket than in the first two.
Jim Cramer: This Market Values Companies With a Heart
Brains per share. Hearts Per Share. I've been around long enough to be that positive. I like these companies and more importantly, I like their stocks.
Why Am I Surprised That Kimberly-Clark Shares Are Acting So Well?
I'm thinking that I probably take a pass on this name today.
Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials
Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.
Jim Cramer: The Great Oil Disconnect
In any other business, if you saw demand fall, you would make less, but what did oil producers do as Covid-19 stopped people from driving, flying and leaving home?
The Week Ahead: Jobless Claims, PMI Data and 35 Key Earnings Reports to Watch
More than 450 quarterly reports are on tap, including 105 S&P 500 constituents.
I'm Dusting Off My Old Playbook for Bonds Right Now
After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.
Stock Up: This Dividend Aristocrat Is Immune From Coronavirus
Consumer staples' recession-resistant qualities are highly appealing to income and dividend growth investors.
Jim Cramer: 6 Stocks to Buy on Coronavirus Fears
These companies all could be strong -- even if the 2019 nCoV fear spreads.
The Coronavirus Impact on Markets, Trump at Davos, Hot Housing, Trading Zscaler
The market impact of the virus for U.S. investors has been seen in more pronounced fashion in Treasury markets.
The Week Ahead: Davos, Impeachment, PMI and 25 Key Earnings Reports to Watch
Almost 200 companies are slated to report quarterly results, including 43 S&P 500 constituents.
There Is Always a Bear Market Somewhere!
To turn Jim "El Capitan" Cramer's watchword of his investment faith around, there is always a bear market somewhere. Today and yesterday I took very nice gains in shorts in , , and .
Covering KMB, CL
I shorted about a week ago. Though KMB had a small EPS beat it was not enough considering the advance of the share price recently. The shares are -$7.40/share (or -5.4%) and I have just covered my trading short rental in this name at $131.70 for a g...
China Trade Optimism, Do Boeing's Numbers Matter? Trading Apple: Market Recon
There is a chance that Presidents Trump and Xi sign something when they meet up at the APEC summit this November in Santiago, Chile.
Kimberly-Clark Is Poised to Break Out From This Rare Chart Pattern
KMB is set to report quarterly results on Tuesday.
Key Market Observations
As mentioned earlier, breadth was only 2-1 positive with UnitedHealth , JPMorgan and Johnson & Johnson responsible for a large portion of the market's gains. Bond yields rose, aiding the rate-sensitive banks (who generally met expectations). FANG ha...
Defensives Are Offensive
Consumer non durables' weakness is conspicuous. (Ck out ) and are my new short names over the last few trading sessions.
My Recent Trading and Investing
I was quite active in my trading and investing over the last two days (while I was on the West Coast and not writing in my Diary). Here is a summary of my actions: * I have added to my private equity shorts - (a new position) joins . * I have reesta...
Jim Cramer: Welcome to a Market Filled With Fear
The impact of Elizabeth Warren is pretty much everywhere Thursday.
Jim Cramer: It's Looking Like the 1980s
Kimberly-Clark's performance is nothing to sneeze at, and neither is Coca-Cola's, as higher sales, higher prices and big demand from emerging markets appear to give us a return to the good old days of great senior growth stocks.
